ONYX BIOTEC LIMITED

13 Nov 2024 - 18 Nov 2024 Individual Category IPO NSE

Min Investment

₹122000

Price Band

₹58-₹61

Issue Size

34.44 lakhs
Equity Shares

Lot Size

2000

IPO Dates
img

13 Nov 2024

Open Date

img

18 Nov 2024

Close Date

img

19 Nov 2024

Allotment Date

img

21 Nov 2024

Listing Date

Onyx Biotec IPO issue size is 48.10 lakh equity shares. This IPO is offering entirely a fresh issue. The price band is decided at Rs 58 to Rs 61 per share. Onyx Biotec IPO 1 lot consists of 2000 shares. The minimum investment for the retail category is to be around Rs 122,000. The allotment status will be released on Tuesday, November 19, 2024. The listing will be on the NSE SME platform on Thursday, November 21, 2024. Onyx Biotec IPO registrar is Mas Services Limited. On the date of allotment, Investors can visit on Mas Services Limited website and, select the name of the company and enter PAN number or application ID to know their allotment status.

Know Before Investing

Strengths icon

Weaknesses icon

About Onyx Biotec Limited

Onyx Biotec Limited, established in 2005, is a prominent pharmaceutical company based in Himachal Pradesh, India. Specializing in the production of parenteral products, it offers a range of sterile solutions, including polyethene ampoules. Onyx Biotec has received recognition for its commitment to quality and innovation in drug manufacturing. Its focus on meeting healthcare needs places the company in an important position to supply essential medications across the region. With its strategic location near Solan, its distribution capabilities are well enhanced to provide efficient service delivery. As an exact brand name that encourages trust in the pharmacy market, Onyx Biotec continues to further the development of products while upholding regulatory rigour at its best, thus contributing substantially towards the health sector of India.

Founded

2005

Managing Director

Sanjay Jain

Parent Organization

IPO Objectives

The company plans to use the Net Proceeds from the issue to upgrade its existing manufacturing Unit I to produce large-volume parentals for intravenous use, establish a high-speed carton packaging line at manufacturing Unit II for dry powder injections, repay or prepay a portion of its loans, and for general corporate purposes.

Company Promoters

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account